LUMIGAN 0.3 mg/ml, eye drop solution bottle, 3 ml, parallel import (Pharma Lab)
Active ingredients: Bimatoprost
Commercialized according to BDPMDispensing in France: Prescription only
Eye drop solutionbottle, 3 ml, parallel import (Pharma Lab)ophtalmique
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LUMIGAN 0,3 mg/ml, collyre en solution
- Pharmaceutical form
- collyre en solution
- Route of administration
- ophtalmique
- Presentation description
- 1 flacon(s) polyéthylène basse densité (PEBD) de 3 ml(Distributeur parallèle : Pharma Lab)
- Marketing authorisation holder
- ABBVIE DEUTSCHLAND (ALLEMAGNE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 22 Feb 2016
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60135981CIP74950008CIP133400949500086Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BIMATOPROSTcollyre | 0,3 mg · 1 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.